Corrigendum to “Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study” [Heliyon 8 (6) (2022) e09538]

In the original published version of this article one of the authors names was misspelt. The correct spelling of Nijia Chang is to Nijia Chang. The correct spelling of the name of the author can also be found below. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors.

Name: Nijia Chang

Affiliation: The Second Medical Center of PLA General Hospital, Beijing, 100039, China